Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Calvez

Showing results (41-50 of 141) with videos related to

Pageof 15
Sort By:
AIDS (London, England)|September 26, 1997
No effect of protease inhibitor on clinical and virological evolution of Castleman's disease in an HIV-1-infected patientN Dupin, A Krivine, V Calvez, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|April 30, 1998
Susceptibility of peripheral blood mononuclear cells to apoptosis is correlated to plasma HIV loadM Karmochkine, C Parizot, V Calvez, et al.
Lancet (London, England)|September 12, 1998
Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 diseaseT S Li, R Tubiana, C Katlama, et al.
Theoretical Population Biology|May 12, 2023
Adaptation of a quantitative trait to a changing environment: New analytical insights on the asexual and infinitesimal sexual modelsJ Garnier, O Cotto, E Bouin, et al.
Virology|October 1, 1995
Cell clones cured of persistent poliovirus infection display selective permissivity to the wild-type poliovirus strain Mahoney and partial resistance to the attenuated Sabin 1 strain and Mahoney mutantsV Calvez, I Pelletier, T Couderc, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 23, 1998
The level of human immunodeficiency virus (HIV) type 1 RNA in cerebrospinal fluid as a marker of HIV encephalitisP Bossi, N Dupin, A Coutellier, et al.
Journal of the National Cancer Institute|April 20, 2000
Transactivation of the metallothionein promoter in cisplatin-resistant cancer cells: a specific gene therapy strategyD Vandier, V Calvez, L Massade, et al.
Journal of Virology|September 12, 2000
Immunogenicity of mutations induced by nucleoside reverse transcriptase inhibitors for human immunodeficiency virus type 1-specific cytotoxic T cellsA Samri, G Haas, J Duntze, et al.
Annals of the New York Academy of Sciences|May 25, 1995
Persistent poliovirus infection: development of new models with cell linesV Calvez, I Pelletier, N Guedo, et al.
Lancet (London, England)|October 31, 1997
HHV-8 and multiple myeloma in FranceA G Marcelin, N Dupin, D Bouscary, et al.
Pageof 15

Showing results (41-50 of 141) with videos related to

Sort By:
Pageof 15
AIDS (London, England)|September 26, 1997
No effect of protease inhibitor on clinical and virological evolution of Castleman's disease in an HIV-1-infected patientN Dupin, A Krivine, V Calvez, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|April 30, 1998
Susceptibility of peripheral blood mononuclear cells to apoptosis is correlated to plasma HIV loadM Karmochkine, C Parizot, V Calvez, et al.
Lancet (London, England)|September 12, 1998
Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 diseaseT S Li, R Tubiana, C Katlama, et al.
Theoretical Population Biology|May 12, 2023
Adaptation of a quantitative trait to a changing environment: New analytical insights on the asexual and infinitesimal sexual modelsJ Garnier, O Cotto, E Bouin, et al.
Virology|October 1, 1995
Cell clones cured of persistent poliovirus infection display selective permissivity to the wild-type poliovirus strain Mahoney and partial resistance to the attenuated Sabin 1 strain and Mahoney mutantsV Calvez, I Pelletier, T Couderc, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 23, 1998
The level of human immunodeficiency virus (HIV) type 1 RNA in cerebrospinal fluid as a marker of HIV encephalitisP Bossi, N Dupin, A Coutellier, et al.
Journal of the National Cancer Institute|April 20, 2000
Transactivation of the metallothionein promoter in cisplatin-resistant cancer cells: a specific gene therapy strategyD Vandier, V Calvez, L Massade, et al.
Journal of Virology|September 12, 2000
Immunogenicity of mutations induced by nucleoside reverse transcriptase inhibitors for human immunodeficiency virus type 1-specific cytotoxic T cellsA Samri, G Haas, J Duntze, et al.
Annals of the New York Academy of Sciences|May 25, 1995
Persistent poliovirus infection: development of new models with cell linesV Calvez, I Pelletier, N Guedo, et al.
Lancet (London, England)|October 31, 1997
HHV-8 and multiple myeloma in FranceA G Marcelin, N Dupin, D Bouscary, et al.
Pageof 15